PortfoliosLab logoPortfoliosLab logo
NUS vs. COCO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NUS vs. COCO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nu Skin Enterprises, Inc. (NUS) and The Vita Coco Company, Inc. (COCO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NUS achieves a -47.13% return, which is significantly lower than COCO's 56.35% return.


NUS

1D
-0.40%
1M
-14.83%
YTD
-47.13%
6M
-49.64%
1Y
-33.40%
3Y*
-44.26%
5Y*
-36.42%
10Y*
-17.12%

COCO

1D
-1.36%
1M
9.00%
YTD
56.35%
6M
55.24%
1Y
135.99%
3Y*
43.14%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

NUS vs. COCO - Yearly Performance Comparison


2026 (YTD)20252024202320222021
NUS
Nu Skin Enterprises, Inc.
-47.13%43.29%-63.67%-51.07%-13.92%24.44%
COCO
The Vita Coco Company, Inc.
56.35%43.62%43.90%85.60%23.72%-27.33%

Correlation

The correlation between NUS and COCO is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.09

Correlation (All Time)
Calculated using the full available price history since Oct 21, 2021

0.16

Fundamentals

Market Cap

NUS:

$247.11M

COCO:

$5.01B

EPS

NUS:

$1.10

COCO:

$1.38

PE Ratio

NUS:

4.57

COCO:

60.07

PEG Ratio

NUS:

0.01

COCO:

0.50

PS Ratio

NUS:

0.17

COCO:

7.56

PB Ratio

NUS:

0.31

COCO:

14.23

Total Revenue (TTM)

NUS:

$1.44B

COCO:

$658.62M

Gross Profit (TTM)

NUS:

$998.90M

COCO:

$246.32M

EBITDA (TTM)

NUS:

$115.40M

COCO:

$100.45M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NUS vs. COCO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NUS
NUS Risk / Return Rank: 1717
Overall Rank
NUS Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
NUS Sortino Ratio Rank: 1717
Sortino Ratio Rank
NUS Omega Ratio Rank: 1616
Omega Ratio Rank
NUS Calmar Ratio Rank: 2222
Calmar Ratio Rank
NUS Martin Ratio Rank: 1717
Martin Ratio Rank

COCO
COCO Risk / Return Rank: 9393
Overall Rank
COCO Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
COCO Sortino Ratio Rank: 9292
Sortino Ratio Rank
COCO Omega Ratio Rank: 9191
Omega Ratio Rank
COCO Calmar Ratio Rank: 9494
Calmar Ratio Rank
COCO Martin Ratio Rank: 9494
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NUS vs. COCO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nu Skin Enterprises, Inc. (NUS) and The Vita Coco Company, Inc. (COCO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NUSCOCODifference
Sharpe ratioReturn per unit of total volatility

-3.26

Sortino ratioReturn per unit of downside risk

-4.03

Omega ratioGain probability vs. loss probability

0.91

1.45

-0.54

Calmar ratioReturn relative to maximum drawdown

-0.56

5.89

-6.44

Martin ratioReturn relative to average drawdown

-1.13

16.49

-17.61

NUS vs. COCO - Sharpe Ratio Comparison

The current NUS Sharpe Ratio is -0.64, which is lower than the COCO Sharpe Ratio of 2.62. The chart below compares the historical Sharpe Ratios of NUS and COCO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NUS vs. COCO - Drawdown Comparison

The maximum NUS drawdown since its inception was -94.63%, which is greater than COCO's maximum drawdown of -56.97%. Use the drawdown chart below to compare losses from any high point for NUS and COCO.


Loading charts...

Drawdown Indicators


NUSCOCODifference

Max Drawdown

Largest peak-to-trough decline

-94.63%

-56.97%

-37.66%

Max Drawdown (1Y)

Largest decline over 1 year

-60.32%

-23.23%

-37.09%

Max Drawdown (3Y)

Largest decline over 3 years

-83.49%

-38.55%

-44.94%

Max Drawdown (5Y)

Largest decline over 5 years

-89.79%

Max Drawdown (10Y)

Largest decline over 10 years

-92.37%

Current Drawdown

Current decline from peak

-94.61%

-1.36%

-93.25%

Average Drawdown

Average peak-to-trough decline

-48.14%

-16.75%

-31.39%

Ulcer Index

Depth and duration of drawdowns from previous peaks

29.67%

8.28%

+21.39%

Volatility

NUS vs. COCO - Volatility Comparison

Nu Skin Enterprises, Inc. (NUS) and The Vita Coco Company, Inc. (COCO) have volatilities of 10.08% and 9.73%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NUSCOCODifference

Volatility (1M)

Calculated over the trailing 1-month period

10.08%

9.73%

+0.35%

Volatility (6M)

Calculated over the trailing 6-month period

33.46%

41.59%

-8.13%

Volatility (1Y)

Calculated over the trailing 1-year period

52.82%

52.27%

+0.55%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

47.06%

56.69%

-9.63%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.07%

56.69%

-7.62%

Dividends

NUS vs. COCO - Dividend Comparison

NUS's dividend yield for the trailing twelve months is around 4.80%, while COCO has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
COCO
The Vita Coco Company, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NUS
Nu Skin Enterprises, Inc.
4.80%2.49%3.48%8.03%3.65%3.00%2.75%3.61%2.38%2.11%2.97%3.69%

Financials

NUS vs. COCO - Financials Comparison

This section allows you to compare key financial metrics between Nu Skin Enterprises, Inc. and The Vita Coco Company, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


100.00M200.00M300.00M400.00M500.00M600.00M700.00M20222023202420252026
320.61M
179.77M
(NUS) Total Revenue
(COCO) Total Revenue
Values in USD except per share items

NUS vs. COCO - Profitability Comparison

The chart below illustrates the profitability comparison between Nu Skin Enterprises, Inc. and The Vita Coco Company, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%80.0%20222023202420252026
66.9%
40.0%
Portfolio components
NUS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Nu Skin Enterprises, Inc. reported a gross profit of 214.46M and revenue of 320.61M. Therefore, the gross margin over that period was 66.9%.

COCO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, The Vita Coco Company, Inc. reported a gross profit of 71.81M and revenue of 179.77M. Therefore, the gross margin over that period was 40.0%.

NUS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Nu Skin Enterprises, Inc. reported an operating income of 4.03M and revenue of 320.61M, resulting in an operating margin of 1.3%.

COCO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, The Vita Coco Company, Inc. reported an operating income of 33.58M and revenue of 179.77M, resulting in an operating margin of 18.7%.

NUS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Nu Skin Enterprises, Inc. reported a net income of 1.84M and revenue of 320.61M, resulting in a net margin of 0.6%.

COCO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, The Vita Coco Company, Inc. reported a net income of 30.47M and revenue of 179.77M, resulting in a net margin of 17.0%.


Frequently Asked Questions


NUS and COCO have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NUS has higher volatility (10.08%) compared to COCO (9.73%). In terms of maximum drawdown, NUS dropped -94.63% vs COCO's -56.97%.

COCO currently has the higher Sharpe Ratio (2.62 vs -0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NUS and COCO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer